Please login to the form below

Not currently logged in
Email:
Password:

Prescription Digital Therapeutics

This page shows the latest Prescription Digital Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Pear Therapeutics submits latest digital therapeutic, insomnia and depression treatment

Pear Therapeutics submits latest digital therapeutic, insomnia and depression treatment

Pear Therapeutics is a pioneer of so-called digital therapeutics, having gained the first ever such approval from the FDA in 2017, for its treatment for patients with Substance Use Disorder ... Its Prescription Digital Therapeutics (PDTs) are app-based

Latest news

  • FDA clears Sandoz and Pear’s Opioid Use Disorder app FDA clears Sandoz and Pear’s Opioid Use Disorder app

    validated software-based therapeutics, known as Prescription Digital Therapeutics (PDT). ... Richard Francis, CEO, Sandoz. "New digital therapeutics such as reSET-O also have the potential to fundamentally change how patients interact with their

  • Novartis plans digital therapeutics for schizophrenia and MS Novartis plans digital therapeutics for schizophrenia and MS

    Novartis shares our vision for prescription digital therapeutics that work alongside drugs to deliver superior patient outcomes. ... We believe this collaboration further supports the clinical viability of prescription digital therapeutics as an emerging

  • FDA approves first substance use mobile medical application FDA approves first substance use mobile medical application

    Corey McCann, Pear’s president and CEO, said: “This is a defining moment for digital therapeutics and for patients with substance use disorder. ... We believe that prescription digital therapeutics hold promise in improving patient outcomes across a

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
Gilead Headquarters
The search for effective drug treatments for COVID-19
PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...

Infographics